AUSTAR maintains 512.58 million issued shares in June 2026; public float requirement met

Bulletin Express07-02

Hong Kong–listed AUSTAR Lifesciences Limited released its Monthly Return for Equity Issuer for the period ended 30 June 2026, indicating stable capital metrics throughout the month.

Authorised and registered share capital • The company’s authorised capital stood unchanged at 10.00 billion ordinary shares with a par value of HKD 0.01 each, equivalent to HKD 100.00 million.

Issued share capital and treasury shares • Issued shares (excluding treasury shares) remained at 512.58 million. • AUSTAR held no treasury shares, and there were no share cancellations, repurchases or new issuances during the month.

Public float compliance • Management confirmed that, as of 30 June 2026, the company satisfied the Hong Kong Main Board’s minimum public float threshold of 25 per cent of issued shares.

Capital instruments • The filing shows no outstanding share options, warrants, convertible securities or other equity-settled arrangements.

Governance note • The monthly return was submitted by Company Secretary Mak Yuk Kiu on 2 July 2026, in accordance with Hong Kong Exchange disclosure requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1117977744?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-02 14:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1117977744","market":"hk","top_or_hot":-1,"title":"AUSTAR maintains 512.58 million issued shares in June 2026; public float requirement met","media":"Bulletin Express","content":"<p>Hong Kong–listed AUSTAR Lifesciences Limited released its Monthly Return for Equity Issuer for the period ended 30 June 2026, indicating stable capital metrics throughout the month.</p>\n<p>Authorised and registered share capital  \n• The company’s authorised capital stood unchanged at 10.00 billion ordinary shares with a par value of HKD 0.01 each, equivalent to HKD 100.00 million.</p>\n<p>Issued share capital and treasury shares  \n• Issued shares (excluding treasury shares) remained at 512.58 million.  \n• AUSTAR held no treasury shares, and there were no share cancellations, repurchases or new issuances during the month.</p>\n<p>Public float compliance  \n• Management confirmed that, as of 30 June 2026, the company satisfied the Hong Kong Main Board’s minimum public float threshold of 25 per cent of issued shares.</p>\n<p>Capital instruments  \n• The filing shows no outstanding share options, warrants, convertible securities or other equity-settled arrangements.</p>\n<p>Governance note  \n• The monthly return was submitted by Company Secretary Mak Yuk Kiu on 2 July 2026, in accordance with Hong Kong Exchange disclosure requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AUSTAR maintains 512.58 million issued shares in June 2026; public float requirement met</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAUSTAR maintains 512.58 million issued shares in June 2026; public float requirement met\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-02 14:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong–listed AUSTAR Lifesciences Limited released its Monthly Return for Equity Issuer for the period ended 30 June 2026, indicating stable capital metrics throughout the month.</p>\n<p>Authorised and registered share capital  \n• The company’s authorised capital stood unchanged at 10.00 billion ordinary shares with a par value of HKD 0.01 each, equivalent to HKD 100.00 million.</p>\n<p>Issued share capital and treasury shares  \n• Issued shares (excluding treasury shares) remained at 512.58 million.  \n• AUSTAR held no treasury shares, and there were no share cancellations, repurchases or new issuances during the month.</p>\n<p>Public float compliance  \n• Management confirmed that, as of 30 June 2026, the company satisfied the Hong Kong Main Board’s minimum public float threshold of 25 per cent of issued shares.</p>\n<p>Capital instruments  \n• The filing shows no outstanding share options, warrants, convertible securities or other equity-settled arrangements.</p>\n<p>Governance note  \n• The monthly return was submitted by Company Secretary Mak Yuk Kiu on 2 July 2026, in accordance with Hong Kong Exchange disclosure requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06118","symbol_name":"奥星生命科技","start_time":0,"source_url":"","article_id":"1117977744","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1117977744","pubTimestamp":1782974812,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong–listed AUSTAR Lifesciences Limited released its Monthly Return for Equity Issuer for the period ended 30 June 2026, indicating stable capital metrics throughout the month. Authorised and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06118":"奥星生命科技"},"translate_title":"奥星2026年6月维持5.1258亿股已发行股份；符合公众持股量要求","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06118":1},"content_text":"Hong Kong–listed AUSTAR Lifesciences Limited released its Monthly Return for Equity Issuer for the period ended 30 June 2026, indicating stable capital metrics throughout the month.\nAuthorised and registered share capital  \n• The company’s authorised capital stood unchanged at 10.00 billion ordinary shares with a par value of HKD 0.01 each, equivalent to HKD 100.00 million.\nIssued share capital and treasury shares  \n• Issued shares (excluding treasury shares) remained at 512.58 million.  \n• AUSTAR held no treasury shares, and there were no share cancellations, repurchases or new issuances during the month.\nPublic float compliance  \n• Management confirmed that, as of 30 June 2026, the company satisfied the Hong Kong Main Board’s minimum public float threshold of 25 per cent of issued shares.\nCapital instruments  \n• The filing shows no outstanding share options, warrants, convertible securities or other equity-settled arrangements.\nGovernance note  \n• The monthly return was submitted by Company Secretary Mak Yuk Kiu on 2 July 2026, in accordance with Hong Kong Exchange disclosure requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1117977744","isCrawlerRequest":true}